Nigerian Breast Cancer Risk-Reduction Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- CELIA IMARIA AGWAI, M.P.H; Ph.D.
University of Ibadan
Principal Investigator - DEZHENG HUO, PhD
University of Chicago
Study Director - IKEOLUWAPO O. AJAYI, MBBS; PhD
University of Ibadan
Principal Investigator - OLADELE O.O KALE, B.A, M.B, B.Ch, B.A.O
University of Ibadan
Principal Investigator - OLADOSUN A OJENGBEDE, FMCOG, FWACS, FICS, M.B.B.S
CENTER FOR POPULATION AND REPRODUCTIVE HEALTH (CPRH), UNIVERSITY COLLEGE HOSPITAL, IBADAN
Principal Investigator - OLUFUNMILAYO OLOPADE, M.D., F.A.C.P
University of Chicago
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Obafemi Awolowo University Teaching Hospital Complex (oauthc)
Ile-Ife, Osun State, Nigeria
- University College Hospital (uch)
Ibadan, Oyo State, Nigeria
- Lagos State University Teaching Hospital (lasuth)
Lagos, Nigeria
- Lagos University Teaching Hospital (luth)
Lagos, Nigeria
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Feb 2017
- Primary completion
- 29 Oct 2021
- Completion
- 29 Oct 2021
- Last update posted
- 3 Aug 2023
- Registered enrollment
- 719
- Registry id
- NCT05834933
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.